Nemes Balázs, Gámán György, Doros Attila
Division of Transplantation, Institute of Surgery, Clinical Centre, University of Debrecen, Moricz Zs. krt. 22, Debrecen, H-4032, Hungary.
Expert Rev Gastroenterol Hepatol. 2015 Apr;9(4):447-66. doi: 10.1586/17474124.2015.967761. Epub 2014 Oct 21.
Biliary complications (BCs) remain one of the most outstanding factors influencing long-term results after orthotopic liver transplantation. The authors carried out a systematic overview of 1720 papers since 2008, and focused on 45 relevant ones. Among 14,411 transplanted patients the incidence of BCs was 23%. Biliary leakage occurred in 8.5%, biliary stricture in 14.7%, mortality rate was 1-3%.
preoperative sodium level; p = 0.037, model of end-stage liver disease score >25; p = 0.048, primary sclerosing cholangitis; p = 0.001, malignancy; p = 0.026, donor age >60, macrovesicular graft steatosis; p = 0.001, duct-to-duct anastomosis; p = 0.004, long anhepatic phase; p = 0.04, cold ischemic time >12 h; p = 0.043, use of T-tube; p = 0.032, insufficient flush of bile ducts; p = 0.001, acute rejection; p = 0.003, cytomegalovirus infection; p = 0.004 and hepatic artery thrombosis; p = 0.001. The management was surgical in case of biliary leakage, and interventional radiology or endoscopic retrograde cholangiopancreatography in case of biliary stricture. Mapping of miRNA profile is a new field of research. Nemes-Doros score is a useful tool in the estimation of hepatic artery thrombosis. Management of BCs requires a multidisciplinary expert team.
胆系并发症(BCs)仍然是影响原位肝移植术后长期效果的最显著因素之一。作者对2008年以来的1720篇论文进行了系统综述,并重点关注了45篇相关论文。在14411例肝移植患者中,BCs的发生率为23%。胆漏发生率为8.5%,胆管狭窄发生率为14.7%,死亡率为1% - 3%。
术前血钠水平;p = 0.037,终末期肝病模型评分>25;p = 0.048,原发性硬化性胆管炎;p = 0.001,恶性肿瘤;p = 0.026,供体年龄>60岁,移植肝大泡性脂肪变性;p = 0.001,端端吻合;p = 0.004,无肝期延长;p = 0.04,冷缺血时间>12小时;p = 0.043,使用T管;p = 0.032,胆管冲洗不充分;p = 0.001,急性排斥反应;p = 0.003,巨细胞病毒感染;p = 0.004以及肝动脉血栓形成;p = 0.001。胆漏时采用手术治疗,胆管狭窄时采用介入放射学或内镜逆行胰胆管造影术治疗。微小RNA谱的绘制是一个新的研究领域。内梅斯 - 多罗斯评分是评估肝动脉血栓形成的有用工具。BCs的管理需要一个多学科专家团队。